No such message found

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Will we hold our big gain today?
Reply New Message
Prev Message Back To Forum Threaded View Next Message

Rocketman,

I think you meant to post this on the Resverlogix board.

"I’ll be surprised if we continue up or even hold the huge jump of yesterday....but I’d be pleased to be surprised! Exciting days, weeks and months ahead as we all anticipate coming events....Certainly would be great to get the seventh safety report in the next week or so."

3 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply